Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Moiseev

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Terapevticheskii Arkhiv|January 1, 1989
[Heart involvement in hypereosinophilia: the restrictive or the dilated type?]S V Moiseev, E N Semenkova, N P ShatkovskiÄ­
Klinicheskaia Meditsina|April 27, 2004
[Clinical aspects of hypereosinophilia syndrome]E N Semenkova, S V Moiseev, O G Namestnikova
Terapevticheskii Arkhiv|February 1, 2019
The modern therapy of systemic vasculitides: perspectives and challengesP I Novikov, A S Zykova, S V Moiseev
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 15, 2011
[Reduced glomerular filtration rate as a marker of cardiovascular risk in the general population]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|December 25, 2007
[High risk arterial hypertension: the role of angiotensin II receptor blockers]V V Fomin, S V Moiseev, N A Mukhin
Klinicheskaia Meditsina|October 13, 2005
[Contemporary drug therapy: dramatic dangers and the optimism of ability]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|February 14, 2007
[Evolution of the ideas about arterial hypertension in the papers of E.M. Tareev]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|May 11, 2023
[Gout: from Hippocrates till the modern time]S V Guliaev, N V Chebotareva, S V Moiseev
Klinicheskaia Meditsina|October 20, 2001
[Clinical aspects and diagnosis of mitral prolapse]V V Fomin, S V Moiseev, I A Sarkisova
Klinicheskaia Meditsina|January 31, 2009
[Microalbuminuria, a universal marker of unfavourable prognosis]N A Mukhin, V V Fomin, S V Moiseev
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Terapevticheskii Arkhiv|January 1, 1989
[Heart involvement in hypereosinophilia: the restrictive or the dilated type?]S V Moiseev, E N Semenkova, N P ShatkovskiÄ­
Klinicheskaia Meditsina|April 27, 2004
[Clinical aspects of hypereosinophilia syndrome]E N Semenkova, S V Moiseev, O G Namestnikova
Terapevticheskii Arkhiv|February 1, 2019
The modern therapy of systemic vasculitides: perspectives and challengesP I Novikov, A S Zykova, S V Moiseev
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|March 15, 2011
[Reduced glomerular filtration rate as a marker of cardiovascular risk in the general population]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|December 25, 2007
[High risk arterial hypertension: the role of angiotensin II receptor blockers]V V Fomin, S V Moiseev, N A Mukhin
Klinicheskaia Meditsina|October 13, 2005
[Contemporary drug therapy: dramatic dangers and the optimism of ability]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|February 14, 2007
[Evolution of the ideas about arterial hypertension in the papers of E.M. Tareev]N A Mukhin, S V Moiseev, V V Fomin
Terapevticheskii Arkhiv|May 11, 2023
[Gout: from Hippocrates till the modern time]S V Guliaev, N V Chebotareva, S V Moiseev
Klinicheskaia Meditsina|October 20, 2001
[Clinical aspects and diagnosis of mitral prolapse]V V Fomin, S V Moiseev, I A Sarkisova
Klinicheskaia Meditsina|January 31, 2009
[Microalbuminuria, a universal marker of unfavourable prognosis]N A Mukhin, V V Fomin, S V Moiseev
Pageof 12